Pablo Colorado

2.8k total citations
21 papers, 2.0k citations indexed

About

Pablo Colorado is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Immunology and Allergy. According to data from OpenAlex, Pablo Colorado has authored 21 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Immunology and Allergy. Recurrent topics in Pablo Colorado's work include Pulmonary Hypertension Research and Treatments (7 papers), Cell Adhesion Molecules Research (6 papers) and Heart Failure Treatment and Management (4 papers). Pablo Colorado is often cited by papers focused on Pulmonary Hypertension Research and Treatments (7 papers), Cell Adhesion Molecules Research (6 papers) and Heart Failure Treatment and Management (4 papers). Pablo Colorado collaborates with scholars based in United States, Germany and Italy. Pablo Colorado's co-authors include Raghu Kalluri, Yohei Maeshima, Adriana de la Torre, Helmut Hopfer, Vikas P. Sukhatme, George D. Kamphaus, Mark B. Ericksen, Frank Strutz, Gary D. Bonner and Michael Zeisberg and has published in prestigious journals such as Journal of Biological Chemistry, Stroke and CHEST Journal.

In The Last Decade

Pablo Colorado

17 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pablo Colorado United States	12	998	646	561	548	416	21	2.0k
Evangelia Pardali Netherlands	30	2.2k 2.2×	617 1.0×	533 1.0×	199 0.4×	253 0.6×	47	3.7k
Katri Koli Finland	27	1.2k 1.2×	324 0.5×	730 1.3×	193 0.4×	106 0.3×	56	2.4k
Carmen Langa Spain	22	1.2k 1.2×	332 0.5×	656 1.2×	188 0.3×	117 0.3×	36	2.3k
Ryoko Shimizu‐Hirota Japan	21	544 0.5×	312 0.5×	365 0.7×	179 0.3×	212 0.5×	35	1.8k
Karin Weindel Germany	16	1.8k 1.8×	844 1.3×	297 0.5×	179 0.3×	104 0.3×	19	2.6k
Francisco J. Blanco Spain	23	949 1.0×	343 0.5×	546 1.0×	98 0.2×	122 0.3×	30	2.0k
Sébastien P. Tabruyn Belgium	26	1.3k 1.3×	767 1.2×	282 0.5×	78 0.1×	332 0.8×	36	2.4k
Pedro Lastres Spain	20	844 0.8×	207 0.3×	383 0.7×	223 0.4×	58 0.1×	27	1.6k
Fabienne Baffert Switzerland	13	968 1.0×	341 0.5×	223 0.4×	70 0.1×	151 0.4×	19	1.5k
Sunita Patel–Hett United States	14	665 0.7×	202 0.3×	320 0.6×	134 0.2×	203 0.5×	21	1.8k

Countries citing papers authored by Pablo Colorado

Since Specialization

Citations

This map shows the geographic impact of Pablo Colorado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Colorado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Colorado more than expected).

Fields of papers citing papers by Pablo Colorado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Colorado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Colorado. The network helps show where Pablo Colorado may publish in the future.

Co-authorship network of co-authors of Pablo Colorado

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Colorado. A scholar is included among the top collaborators of Pablo Colorado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Colorado. Pablo Colorado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marchis, Gian Marco De, Tolga Dittrich, Dimitrios Vlachos, et al.. (2025). Dual versus single antiplatelet therapy in patients with non-cardioembolic acute ischemic stroke and baseline MRI. European Stroke Journal. 10(3). 766–774.

Udelson, James E., Steven R. Goldsmith, Daniel Burkhoff, et al.. (2025). A Multicentre, Randomized, Double-Blind, Active and Placebo-Controlled Study of Pecavaptan, a Dual V1a/V2 Vasopressin Receptor Antagonist, in Patients with Acute Heart Failure: The AVANTI Trial. European Journal of Heart Failure. 27(11). 2525–2536.

Chen, Chih‐Hao, Ashkan Shoamanesh, Pablo Colorado, et al.. (2025). Hemorrhagic Infarction Does Not Worsen Functional Outcomes in Noncardioembolic Ischemic Stroke: Secondary Analysis From PACIFIC-STROKE. Stroke. 56(7). 1730–1737.

Chen, Chih‐Hao, Ashkan Shoamanesh, Pablo Colorado, et al.. (2024). Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKE. Stroke. 55(6). 1477–1488. 2 indexed citations

Hart, Robert G., Eric E. Smith, Feryal Saad, et al.. (2023). Cerebral microbleeds and asundexian in non-cardioembolic ischemic stroke: Secondary analyses of the PACIFIC-STROKE randomized trial. International Journal of Stroke. 19(5). 526–535. 3 indexed citations

Goldsmith, Steven R., Daniel Burkhoff, Finn Gustafsson, et al.. (2020). Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial. Journal of Cardiac Failure. 27(2). 233–241. 19 indexed citations

Benza, Raymond L., Paul A. Corris, James R. Klinger, et al.. (2018). Switching from PDE5i to Riociguat in the RESPITE Study: Effect on Right Heart Function. The Journal of Heart and Lung Transplantation. 37(4). S152–S152. 2 indexed citations

Halank, Michael, Marius M. Hoeper, Hossein Ardeschir Ghofrani, et al.. (2017). Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study. Respiratory Medicine. 128. 50–56. 29 indexed citations

Hoeper, Marius M., Gérald Simonneau, Paul A. Corris, et al.. (2017). RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors. European Respiratory Journal. 50(3). 1602425–1602425. 104 indexed citations

10.

Benza, Raymond L., Paul Corris, David Langleben, et al.. (2016). The Relationship Between NO Pathway Biomarkers and Response to Riociguat in the RESPITE Study of Patients With PAH Not Reaching Treatment Goals With Phosphodiesterase 5 Inhibitors. CHEST Journal. 150(4). 1316A–1316A.

11.

Simonneau, Gérald, Andrea Maria D’Armini, Hossein Ardeschir Ghofrani, et al.. (2016). Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial. The Lancet Respiratory Medicine. 4(5). 372–380. 104 indexed citations

12.

Simonneau, Gérald, Andrea Maria D’Armini, Hossein Ardeschir Ghofrani, et al.. (2014). Late-breaking abstract: Riociguat for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH): 2-year results from the CHEST-2 long-term extension. European Respiratory Journal. 44(Suppl 58). P1802–P1802. 7 indexed citations

13.

Simonneau, Gérald, Andrea Maria D’Armini, Hossein Ardeschir Ghofrani, et al.. (2014). Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2). European Respiratory Journal. 45(5). 1293–1302. 222 indexed citations

14.

Nyberg, Pia, Liang Xie, Hikaru Sugimoto, et al.. (2008). Characterization of the anti-angiogenic properties of arresten, an α1β1 integrin-dependent collagen-derived tumor suppressor. Experimental Cell Research. 314(18). 3292–3305. 71 indexed citations

15.

Colorado, Pablo, et al.. (2003). CASE REPORT: Liver Abscess and Diarrhea as Initial Manifestations of Ulcerative Colitis: Case Report and Review of the Literature. Digestive Diseases and Sciences. 48(2). 417–421. 18 indexed citations

16.

Zeisberg, Michael, Gary D. Bonner, Yohei Maeshima, et al.. (2001). Renal Fibrosis. American Journal Of Pathology. 159(4). 1313–1321. 256 indexed citations

17.

Maeshima, Yohei, Pablo Colorado, Adriana de la Torre, et al.. (2000). Distinct Antitumor Properties of a Type IV Collagen Domain Derived from Basement Membrane. Journal of Biological Chemistry. 275(28). 21340–21348. 271 indexed citations

18.

Kamphaus, George D., Pablo Colorado, David J. Panka, et al.. (2000). Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth. Journal of Biological Chemistry. 275(2). 1209–1215. 369 indexed citations

19.

Maeshima, Yohei, Pablo Colorado, & Raghu Kalluri. (2000). Two RGD-independent αvβ3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor Properties. Journal of Biological Chemistry. 275(31). 23745–23750. 197 indexed citations

20.

Colorado, Pablo, Adriana de la Torre, George D. Kamphaus, et al.. (2000). Anti-angiogenic cues from vascular basement membrane collagen.. PubMed. 60(9). 2520–6. 326 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact